ATX inhibitor 25 (Compound 29) is an orally active Autotaxin inhibitor with an IC 50 of 1.08 nM. ATX inhibitor 25 exhibits excellent in vitro metabolic stability, with a t 1/2 of more than 170 minutes. In the bleomycin ( HY-108345 )-induced pulmonary fibrosis mouse model, orally administered ATX inhibitor 25 shows anti-fibrotic effects.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Phosphodiesterase (PDE)
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。